CA Stock MarketDetailed Quotes
ZYUS ZYUS Life Sciences Corp
- 1.010
- -0.010-0.98%
15min DelayMarket Closed Jun 28 16:00 ET
71.56MMarket Cap-1741P/E (TTM)
1.010High0.970Low1.00KVolume0.970Open1.020Pre Close974.00Turnover1.41052wk High0.00%Turnover Ratio70.85MShares0.71052wk Low-0.58EPS TTM30.05MFloat Cap2.500Historical HighLossP/E (Static)29.75MShs Float0.710Historical Low-0.76EPS LYR3.92%Amplitude--Dividend TTM3.57P/B1Lot Size--Div YieldTTM
ZYUS Life Sciences Corp Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 46.15%114K | 17.79%351K | 29.33%97K | 17.86%99K | 5.48%77K | 78K | 298K | 75K | 84K | 73K |
| Operating revenue | 46.15%114K | 17.79%351K | 29.33%97K | 17.86%99K | 5.48%77K | --78K | --298K | --75K | --84K | --73K |
| Cost of revenue | 100.00%56K | -66.04%180K | -66.98%35K | 47.37%84K | 32.00%33K | 28K | 530K | 106K | 57K | 25K |
| Gross profit | 16.00%58K | 173.71%171K | 300.00%62K | -44.44%15K | -8.33%44K | 50K | -232K | -31K | 27K | 48K |
| Operating expense | 1.28%3.24M | 8.09%17.36M | 85.45%5.29M | 2.97%3.95M | -32.18%3.03M | 3.2M | 16.06M | 2.85M | 3.84M | 4.46M |
| Selling and administrative expenses | 13.15%2.14M | 33.36%12.6M | 106.37%3.92M | 24.74%2.92M | -21.69%1.96M | --1.89M | --9.45M | --1.9M | --2.34M | --2.5M |
| -Selling and marketing expense | 37.50%77K | -50.38%324K | -17.89%101K | -32.28%86K | -48.41%81K | --56K | --653K | --123K | --127K | --157K |
| -General and administrative expense | 12.40%2.07M | 39.58%12.27M | 114.97%3.82M | 28.01%2.84M | -19.91%1.88M | --1.84M | --8.79M | --1.78M | --2.22M | --2.35M |
| Research and development costs | -12.20%295K | -40.72%1.31M | 168.00%469K | -19.86%222K | -61.74%282K | --336K | --2.21M | --175K | --277K | --737K |
| Depreciation amortization depletion | -22.39%721K | -23.21%3.11M | 5.43%815K | -30.28%760K | -44.62%602K | --929K | --4.05M | --773K | --1.09M | --1.09M |
| -Depreciation and amortization | -22.39%721K | -23.21%3.11M | 5.43%815K | -30.28%760K | -44.62%602K | --929K | --4.05M | --773K | --1.09M | --1.09M |
| Other operating expenses | 95.35%84K | -3.56%352K | 2,000.00%84K | -65.32%43K | 34.81%182K | --43K | --365K | --4K | --124K | --135K |
| Operating profit | -1.05%-3.19M | -5.50%-17.19M | -81.30%-5.23M | -3.31%-3.93M | 32.44%-2.98M | -3.15M | -16.3M | -2.88M | -3.81M | -4.41M |
| Net non-operating interest income (expenses) | 84.77%-245K | 29.63%-3.85M | 69.79%-486K | 79.76%-301K | -418.57%-6.51M | -1.61M | -5.46M | -1.61M | -1.49M | -1.26M |
| Non-operating interest expense | -87.98%185K | -37.59%3.27M | -85.78%212K | -84.98%219K | 418.57%6.51M | --1.54M | --5.24M | --1.49M | --1.46M | --1.26M |
| Total other finance cost | -14.29%60K | 159.28%573K | 132.20%274K | 182.76%82K | ---- | --70K | --221K | --118K | --29K | ---- |
| Other net income (expenses) | 182.42%75K | -827.00%-27.4M | -1,534.20%-24.56M | 101.02%21K | -1,254.05%-2.51M | -91K | -2.96M | -1.5M | -2.06M | -185K |
| Gain on sale of security | 182.42%75K | -7.84%-495K | 116.50%181K | -41.67%21K | -227.03%-605K | ---91K | ---459K | ---1.1M | --36K | ---185K |
| Special income (charges) | ---- | -899.16%-24.95M | -5,994.33%-24.74M | --0 | ---- | ---- | ---2.5M | ---406K | ---2.09M | ---- |
| -Less:Impairment of capital assets | ---- | 988.86%22.77M | --22.77M | --0 | ---- | ---- | --2.09M | --0 | --2.09M | ---- |
| -Less:Write off | ---- | 437.19%2.18M | ---- | ---- | ---- | ---- | --406K | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---- | ---1.96M | --0 | ---- | ---1.9M | ---- | ---- | ---- | ---- | ---- |
| Income before tax | 30.85%-3.36M | -95.99%-48.44M | -405.00%-30.28M | 42.67%-4.21M | -104.90%-12M | -4.85M | -24.72M | -6M | -7.35M | -5.85M |
| Income tax | -6.25%-17K | -9,982.76%-5.85M | -578,900.00%-5.79M | -23.53%-21K | -10.53%-21K | -16K | -58K | -1K | -17K | -19K |
| Earnings from equity interest net of tax | ||||||||||
| Net income | 30.98%-3.34M | -72.73%-42.59M | -308.49%-24.49M | 42.82%-4.19M | -105.21%-11.97M | -4.84M | -24.66M | -5.99M | -7.33M | -5.84M |
| Net income continuous operations | 30.98%-3.34M | -72.73%-42.59M | -308.49%-24.49M | 42.82%-4.19M | -105.21%-11.97M | ---4.84M | ---24.66M | ---5.99M | ---7.33M | ---5.84M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 30.98%-3.34M | -72.73%-42.59M | -308.49%-24.49M | 42.82%-4.19M | -105.21%-11.97M | -4.84M | -24.66M | -5.99M | -7.33M | -5.84M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 30.98%-3.34M | -72.73%-42.59M | -308.49%-24.49M | 42.82%-4.19M | -105.21%-11.97M | -4.84M | -24.66M | -5.99M | -7.33M | -5.84M |
| Diluted earnings per share | 27.78%-0.05 | -115.29%-0.76 | -377.77%-0.41 | 42.85%-0.06 | -235.17%-0.28 | -0.0692 | -0.353 | -0.0858 | -0.105 | -0.0835 |
| Basic earnings per share | 27.78%-0.05 | -115.29%-0.76 | -377.77%-0.41 | 42.85%-0.06 | -235.17%-0.28 | -0.0692 | -0.353 | -0.0858 | -0.105 | -0.0835 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg